|
A
chemical in the hallucinogenic drug known as "magic mushrooms" could
help longtime smokers kick the habit, according to a new study, according to
CBS News.
Researchers
at Johns Hopkins University found that smokers who have a history of failed
cessation attempts were able to successfully quit when they took psilocybin
under the guidance of a physician, along with receiving cognitive behavior
therapy.
For
the study, published in the Journal of Psychopharmacology, researchers gave
doses of psilocybin to 10 men and five women who had a history of heavy
smoking. They smoked an average of 19 cigarettes a day for 31 years and had a
history of failed attempts to quit. Two-thirds of the group reported they'd
used psychedelic drugs recreationally at some point in their life but as much
as three decades before; the remaining five had never taken hallucinogenics.
The
researchers counseled study participants on what effects they might feel from
the drug, then provided one psilocybin pill to each participant on the day they
wished to begin a cessation program. After taking the drug, study participants
spent a session of at least six hours with researchers in a "homelike"
setting. They wore eye shades and headphones to help relax. They were given
additional, higher doses two weeks and eight weeks later.
Each
smoker also received regular cognitive behavior therapy on an individual basis
that included techniques such as keeping a diary to track triggers that
resulted in cigarette cravings.
The
study found that after six months, 80 percent of participants who were given
the psychedelic drug were still not lighting up, compared with 35 percent of
people who took varenicline, the most effective medication currently prescribed
to help smokers quit. Other aids, such as nicotine replacements, typically have
a success rate of less than 30 percent. Researchers also found the
smoking-cessation benefit of psilocybin continued, even after the effects of
the drug wore off.
The
researchers strongly cautioned that their study is not an endorsement of
do-it-yourself psychedelic drug use for smoking cessation.
This
study was federally-funded and part of long-term research into how psychedelic
drugs could be used to help to treat addiction. The researchers plan next to
look at the efficacy of psilocybin versus nicotine patches and use MRIs to
study brain activity.
This is not the first study
to examine how magic mushrooms may alter the brain in therapeutic ways. A study
published in the Proceedings of the National Academy of Science, in 2012, found
that the substance could be an effective treatment for depression. In that
study, brain scans of study participants showed decreased levels of activity in
the "hub" regions of the brain, which are responsible for
consciousness, self-identity, and organizing sensory information.
No comments:
Post a Comment